Limited clinical and cytogenetic information is known about KMT2A-a leukemias; these malignancies are associated with prior exposure to chemotherapy, older age, complex karyotype, and TP53 mutations (41, 42, 43). The gene discussed is KMT2A; the disease is leukemia.